Cho‐Han Chiang
Impact in
-
- Amyotrophic Lateral Sclerosis Research
-
- Neurogenetic and Muscular Disorders Research
Papers in
-
- Diabetes Treatment and Management 8
- Oncology 12
- Cancer Immunotherapy and Biomarkers 5
- Pancreatic and Hepatic Oncology Research 3
- Co-authors
- Hanna S. Yuan (1 shared paper)Lyudmila G. Doudeva (1 shared paper)P.H. Kuo (1 shared paper)Cho‐Hung Chiang (27 shared papers)Yuan Ping Hsia (19 shared papers)Kevin Sheng‐Kai (9 shared papers)Chun-Yu Peng (12 shared papers)Cheng‐Ming Peng (12 shared papers)
- Journals
- Heart (3 papers)Journal of Virology (3 papers)Oncology (3 papers)European Journal of Cancer (2 papers)Blood Advances (2 papers)
- Partner nations
- TaiwanUnited StatesUnited Kingdom
In The Last Decade
Cho‐Han Chiang
57 papers receiving 652 citations
Cho‐Han Chiang's Hit Papers
Peers
Comparison fields: 5 of 82
- Neurology 106
- Genetics 56
- Endocrinology, Diabetes and Metabolism 82
- Internal Medicine 15
- Cardiology and Cardiovascular Medicine 88
Countries citing papers authored by Cho‐Han Chiang
This map shows the geographic impact of Cho‐Han Chiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cho‐Han Chiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cho‐Han Chiang more than expected).
Fields of papers citing papers by Cho‐Han Chiang
This network shows the impact of papers produced by Cho‐Han Chiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cho‐Han Chiang. The network helps show where Cho‐Han Chiang may publish in the future.
Co-authors
The 25 scholars most cited alongside Cho‐Han Chiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 154 | |
| 2 | 2022 | 44 | |
| 3 | 2020 | 38 | |
| 4 | 2018 | 38 | |
| 5 | Glucagon-Like Peptide-1 Receptor Agonists and Gastrointestinal Adverse Events: A Systematic Review and Meta-Analysis Hit paper breakdown → | 2025 | 36 |
| 6 | 2022 | 27 | |
| 7 | 2023 | 21 | |
| 8 | 2024 | 20 | |
| 9 | 2022 | 20 | |
| 10 | 2024 | 19 | |
| 11 | 2020 | 17 | |
| 12 | 2024 | 15 | |
| 13 | 2020 | 12 | |
| 14 | 2023 | 12 | |
| 15 | 2025 | 11 | |
| 16 | 2021 | 10 | |
| 17 | 2025 | 10 | |
| 18 | 2023 | 9 | |
| 19 | 2020 | 9 | |
| 20 | 2024 | 8 |
About Cho‐Han Chiang
Cho‐Han Chiang is a scholar working on Endocrinology, Diabetes and Metabolism, Oncology, Internal Medicine, Cardiology and Cardiovascular Medicine and Epidemiology, having authored 59 papers that have together received 663 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (8 papers), Cancer Immunotherapy and Biomarkers (5 papers), Venous Thromboembolism Diagnosis and Management (4 papers), Metabolism, Diabetes, and Cancer (3 papers), Pancreatic and Hepatic Oncology Research (3 papers), Chemotherapy-induced cardiotoxicity and mitigation (3 papers), Hepatitis B Virus Studies (3 papers) and Hepatitis C virus research (3 papers). The work is most often cited by research in Neurology (106 citations), Genetics (56 citations), Endocrinology, Diabetes and Metabolism (82 citations), Internal Medicine (15 citations) and Cardiology and Cardiovascular Medicine (88 citations). Cho‐Han Chiang has collaborated with scholars based in Taiwan, United States and United Kingdom. Frequent co-authors include Hanna S. Yuan, Lyudmila G. Doudeva, P.H. Kuo, Cho‐Hung Chiang, Yuan Ping Hsia, Kevin Sheng‐Kai, Chun-Yu Peng, Cheng‐Ming Peng, Yu‐Cheng Chang and Li‐Tzu Wang. Their work appears in journals such as Heart, Journal of Virology, Oncology, European Journal of Cancer and Blood Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.